In a head-to-head comparison of sensor-augmented insulin pumps, the touchscreen device from Tandem Diabetes Care outperformed that from Medtronic, according to new data presented at the Annual Advanced Technologies and Treatments for Diabetes conference in Paris.
The self-reported data from San Diego-based Tandem comes from a retrospective study analyzing de-identified data from 3,046 Tandem SAP...
A new clinical trial to investigate the use of artificial pancreas system is set to begin, bringing in touchscreen insulin pump maker Tandem Diabetes Care; Dexcom, which makes continuous glucose monitor; and digital, personalized medicine company TypeZero Technologies.
The International Diabetes Closed Loop trial, funded by a grant from the National Institutes of Health to the University of...